Search Results
Jan 27, 2026, 07:02 ET Univar Solutions and Ashland Forge Exclusive Partnership for Cellulose Ethers in Food and Beverage Sector Throughout EMEA
beverage." The new partnership covers a range of products, including methylcellulose (MC), hydroxypropylmethylcellulose (HPMC), carboxymethylcellulose (CMC), hydroxypropylcellulose (HPC), ethylcellulose (EC), and PVPP. In today's food and beverage manufacturing, cellulose ethers play a versatile and functional
More news about: Univar Solutions LLC
Jan 26, 2026, 09:00 ET Peer AI Appoints David Florez as Vice President of Sales
of hours and improving quality of regulatory documents across pre-clinical, clinical, regulatory affairs, and chemistry, manufacturing, and controls (CMC).Meet Florez and the Peer AI team at the upcoming
More news about: Peer TechBio Inc.
Jan 26, 2026, 02:00 ET HanchorBio and WuXi Biologics Enter Strategic Partnership to Advance Next-Generation Bi-and Multi-Functional Fusion Protein Pipeline
development, drug product formulation development, and GMP manufacturing. The collaboration is designed to accelerate clinical translation, enhance CMC execution efficiency, and support scalable global development and manufacturing of HanchorBio's innovative fusion protein portfolio derived from its
More news about: HanchorBio Inc.
Jan 22, 2026, 17:31 ET Gastroesophageal Reflux Disease Market in the US to Show Promising Growth at a CAGR of 6% During the Forecast Period (2025-2034) | DelveInsight
2025, Cinclus Pharma Holding reported that it received favorable guidance from the US FDA following a recent Chemistry, Manufacturing, and Controls (CMC) meeting, endorsing the continued development of its lead candidate, linaprazan glurate.In October 2025, Phathom Pharmaceuticals announced
More news about: DelveInsight Business Research, LLP
Jan 20, 2026, 12:41 ET OCuSOFT Inc. Launches Retaine® Omega Forté™ Liquid Supplement for Superior Nutritional Support in Dry Eye Management
products including not only the OLS hygiene group but also Retaine® MGD™ Advanced™ preservative-free artificial tears, Retaine® CMC®, HypoChlor® Spray, and many others. OCuSOFT Inc. established the Southwest Research & Technology Center which houses numerous eye
More news about: OCuSOFT Inc.
Jan 14, 2026, 18:36 ET Aging Life Care Association® Welcomes New Board President with Focus on Growth, Community, and Innovation
LCSW, CMC (Past President)Lina Supnet-Zapata, MBA, TxCG, CMC (President-Elect)Annette Murphy, BA, MSW, C-ASWCM (Secretary Treasurer)Ann Burke, MPA, BA, CMCSusan Keating, BSW, CMC, CASPBarbara Levison, MA, MSW, CMCCrystal Littlejohn, MHSA, CMC, CSARebecca
More news about: Aging Life Care Association
Jan 14, 2026, 11:00 ET CMC Electronics is pleased to unveil its latest achievement within the Optoelectronics line - the commercial-off-the-shelf (COTS) family of Pigtailed High-Gain Low-Noise InGaAs Avalanche Photodiodes (APDs)
Optoelectronics - CMC ElectronicsAbout CMC ElectronicsCMC Electronics (cmcelectronics.ca) has achieved an international reputation for innovation and excellence in the design
More news about: CMC Electronics
Jan 13, 2026, 07:42 ET Armata Pharmaceuticals Announces End-of-Phase 2 Meeting with FDA and Plans to Advance AP-SA02 to a Phase 3 Superiority Study in Complicated Staphylococcus aureus Bacteremia
for the treatment of complicated S. aureus bacteremia. Armata is addressing FDA comments, including on Chemistry, Manufacturing, and Controls ("CMC") and aligning them with the Company's existing Phase 3 manufacturing and quality strategy. The FDA also included recommendations for the future Biologics
More news about: Armata Pharmaceuticals, Inc.
Jan 12, 2026, 20:44 ET Oricell Therapeutics Announces US$70M Initial Closing of Series C Financing, to Accelerate Global Development of Solid Tumor CAR-T Therapies
engineering libraryOri®Armoring: enhancement of T-cell persistence and other crucial functions by TAs（Therapeutic Areas）OnGo (Fast) CMC: rapid, scalable and effective manufacturingOricell has generated proof-of-concept (POC) clinical data across multiple pipeline CAR-T products.
More news about: OriCell Therapeutics Co., Ltd.
Jan 08, 2026, 13:31 ET Akadeum Life Sciences to Highlight How Microbubbles Enable Rapid Cell Therapy Manufacturing for Larger Patient Populations at Biotech Showcase 2026
milestone for the platform. The DMF reflects Akadeum's adherence to stringent ancillary material standards for cell and gene therapy and alignment to FDA CMC guidance, enabling developers to confidently adopt Akadeum's
More news about: Akadeum Life Sciences
Jan 08, 2026, 13:00 ET Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman
first the SEC apparently questioning the development disclosures, and then the FDA alleged to have rejected a BLA based on fundamental CMC (Chemistry, Manufacturing, and Controls) and Form 483 deficiencies at the third-party manufacturers," said
More news about: Hagens Berman Sobol Shapiro LLP
Jan 08, 2026, 06:45 ET CMC Reports First Quarter of Fiscal 2026 Results
initiatives. CMC Construction Services and CMC Impact Metals also contributed to year-over-year EBITDA growth, but those contributions were partially offset by lower results for Performance Reinforcing Steel as compared to the elevated levels of a year ago. Net sales and margins within CMC Construction
More news about: Commercial Metals Company
Jan 07, 2026, 08:30 ET Bridging Bench to Bedside: De‑Risking Biotherapeutic Administration via CDMO‑Led Clinical‑Mimic and In‑Use Testing Strategies, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn what clinical in-use studies are and why they matter for biologics safety, efficacy and CMC lifecycle. Attendees will gain insight into designing clinical in-use studies and primary considerations. The featured speakers will discuss analytical method selection for the
More news about: Xtalks
Jan 07, 2026, 07:00 ET Scinai CEO Amir Reichman to Co-Lead Manufacturers Association Biopharma Manufacturing Roundtable at HealthIL
particular focus on early-stage development, CMC activities, and clinical manufacturing across the full development continuum.The discussion will emphasize early-stage development and clinical manufacturing, including access to laboratory infrastructure, CMC and analytical capabilities, and GMP manufacturing
More news about: Scinai Immunotherapeutics Ltd.
Jan 07, 2026, 01:03 ET 에스코 애스터, 샤인온 바이오메디컬과 cGMP 계약 체결
/PRNewswire/ -- JTC 런치패드 싱가포르(LaunchPad Singapore)에 본사를 둔 수직 통합 세포 유래물 CRDMO인 에스코 애스터(Esco Aster)가 샤인온 바이오메디컬(Shine-On Biomedical)의 HLA-G 표적 엑소좀 프로그램에 CMC 제조를 지원한다고 발표했다. 샤인온 바이오메디컬은 2023년에 에스코 애스터의 cGMP 서비스를 후원한 바 있다. 그 시작은 에스코 애스터의 세포주 플랫폼을 이용한 고수율 엑소좀 개발이었다. 공정, 분석 및 제형 개발, 엑소좀 약물 로딩, GMP 엔지니어링 실행, 안정성
More news about: Esco Aster
Jan 06, 2026, 22:09 ET Esco Aster unterzeichnet klinischen cGMP-Herstellungsvertrag mit Shine-On Biomedical für eine neuartige, erstmals in ihrer Klasse verfügbare, HLA-G-gerichtete Exosomenplattform zur Wirkstoffabgabe
vertikal integrierte Auftragsforschungs-, Entwicklungs- und Fertigungsorganisation (CRDMO) für Zellen und Derivate mit Sitz im JTC LaunchPad Singapur, gab CMC-Herstellungsunterstützung für das auf HLA-G ausgerichtete Exosomenprogramm von Shine-On Biomedical bekannt. Shine-On Biomedical unterstützte Esco Aster
More news about: Esco Aster
Jan 06, 2026, 17:14 ET Esco Aster signe avec Shine-On Biomedical un contrat de fabrication clinique d'exosomes, conforme aux BPF en vigueur, pour une nouvelle plateforme HLA-G ciblant l'administration de médicaments exosomiques
contrat (CRDMO) verticalement intégrée, pour les cellules et les dérivés, basé au JTC LaunchPad Singapore, a annoncé son soutien pour la fabrication de CMC dans l e cadre du programme d'exosomes ciblés HLA-G de Shine-On Biomedical. Shine-On Biomedical a parrainé Esco Aster en 2023 pour des services conformes
More news about: Esco Aster
Jan 06, 2026, 12:22 ET Esco Aster assina um contrato de fabricação clínica de exossomos em conformidade com cGMP junto à Shine-On Biomedical para uma nova plataforma de administração de medicamentos à base de exossomos direcionados ao HLA-G, a primeira da sua classe
/PRNewswire/ -- A Esco Aster, uma CRDMO de células e derivados verticalmente integrada sediada no JTC LaunchPad de Singapura, anunciou o suporte de CMC ao programa de exossomos direcionados ao HLA-G da Shine-On Biomedical. A Shine-On Biomedical patrocinou a Esco Aster em 2023 para serviços cGMP, começando
More news about: Esco Aster
Jan 06, 2026, 12:20 ET Esco Aster firma un contrato de fabricación clínica con buenas prácticas de fabricación actuales de exosomas con Shine-On Biomedical para una novedosa plataforma de administración de fármacos basada en exosomas, primera en su clase y dirigida a antígeno leucocitario humano G
investigación, fabricación y desarrollo por contrato (CRDMO, por sus siglas en inglés) con sede en JTC LaunchPad Singapur, anunció el soporte de fabricación de CMC para el programa de exosomas dirigidos a antígeno leucocitario humano G (HLA-G, por sus siglas en inglés) de Shine-On Biomedical. Shine-On Biomedical
More news about: Esco Aster
Jan 06, 2026, 12:00 ET Harvard Pilgrim Health Care, a Point32Health company, honors 34 physician groups in its 24th annual Physician Group Honor Roll
Chapter, NewburyportSouth Shore Medical Center, NorwellUMASS Memorial Medical Group, WorcesterNew HampshireCMC Physician Practice Associates, ManchesterCORE Physicians, ExeterThe Physician Practices at Valley Regional, ClaremontAbout
More news about: Point32Health
Jan 06, 2026, 11:15 ET BRC Therapeutics Announces Peer-Reviewed Publication on Navigating Drug Development Pathways for Botanical Cannabinoid Medicines
Justyna Kulpa, Director of Research and Development at BRC. "At BRC, advancing these products requires tight integration across R&D, manufacturing, CMC, quality, and regulatory functions. This cross-functional collaboration is essential to delivering consistent, standardized medicines and has positioned
More news about: BRC Therapeutics
Jan 06, 2026, 09:47 ET Telix Pharmaceuticals (TLX) Faces Securities Class Action After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability-- Hagens Berman
first the SEC apparently questioning the development disclosures, and then the FDA alleged to have rejected a BLA based on fundamental CMC (Chemistry, Manufacturing, and Controls) and Form 483 deficiencies at the third-party manufacturers," said
More news about: Hagens Berman Sobol Shapiro LLP
Jan 06, 2026, 06:56 ET Esco Aster firma un contrato de fabricación clínica de exosomas con Shine-On Biomedical
desarrollo de desarrollo de células y derivados de células con integración vertical y sede en JTC LaunchPad Singapur, anunció el apoyo de fabricación de CMC para el programa de exosomas dirigidos a HLA-G de Shine-On Biomedical. Shine-On Biomedical patrocinó a Esco Aster en 2023 para servicios de cGMP, comenzando
More news about: Esco Aster
Jan 05, 2026, 23:10 ET Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform
Jan. 6, 2026 /PRNewswire/ -- Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical's HLA-G targeted exosome program. Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP services,
More news about: Esco Aster
Jan 05, 2026, 23:00 ET Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform
Jan. 5, 2026 /PRNewswire/ -- Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical's HLA-G targeted exosome program. Shine-On Biomedical sponsored Esco Aster in 2023 for cGMP services,
More news about: Esco Aster